Kazia Therapeutics (KZIA) Prepaid Assets (2009 - 2016)

Kazia Therapeutics (KZIA) reported Prepaid Assets of $1.9 million for Q4 2016, up 240.24% quarter-over-quarter from $566061.7 in Q2 2016.

Kazia Therapeutics (KZIA) Prepaid Assets (2009 - 2016) Analysis & Trends

Kazia Therapeutics has reported Prepaid Assets for 5 years, with the latest figure at $1.9 million in Q4 2016.

For the quarter ending Q4 2016, Prepaid Assets changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2016 stood at $1.9 million (changed N/A YoY), and the FY2016 full-year result was $552487.6, changed N/A from the prior year.
Prepaid Assets for Q4 2016 stood at $1.9 million, up from $566061.7 in the prior quarter.
The five-year high for Prepaid Assets was $1.9 million in Q4 2016, with the low at $208169.9 in Q2 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Kazia Therapeutics	1.70 Bn	1.70 Bn	-

Download Data